InvestorsHub Logo
Followers 14
Posts 649
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Tuesday, 09/05/2017 3:09:05 PM

Tuesday, September 05, 2017 3:09:05 PM

Post# of 41131
There is no hint of exclusivity in the OEM supply to a large ortho design and manufacturing company in the news release...I just read it again...it sounds like an announcement of a continuation of a strategy at the time of OEM material licensing... So maybe initially Z was happy with a licensing of the material for maybe spine, hip etc... but after so much positive testing, trials and dev work they have changed and are now wanting the whole deal... This scenario leaves more hope that management , and BOD , of amda have been keeping the door at least slightly opened to the industry competition...to make sure Z plays fair...I am thinking Z would be guaranteed use of the material for its own use, at this point, for a predetermined set of products; and this would be laid out in the LOI...So if a competitor outbid Z for amda they would still have to allow Z to access the material as per the terms of the LOI...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News